ALB and Sepsis: In the “Fluid Resuscitation In Sepsis-induced hypotension among patients with Cirrhosis” (FRISC) trial [69] involving cirrhotic patients with sepsis-induced hypotension, 5% human albumin led to better hypotension reversal, improved hemodynamics, and higher short-term survival compared to saline.